help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology Vol. 4, No. 2 184-190
doi:10.1210/mend-4-2-184
Copyright © 1990 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harrison, J. R.
Right arrow Articles by Kream, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harrison, J. R.
Right arrow Articles by Kream, B. E.

Interleukin-1{alpha} and Phorbol Ester Inhibit Collagen Synthesis in Osteoblastic MC3T3-E1 Cells by a Transcriptional Mechanism

John R. Harrison*, Socorro J. Vargas, Donna N. Petersen, Joseph A. Lorenzo and Barbara E. Kream

Department of Medicine, University of Connecticut Health Center Farmington, Connecticut 06032
Department of Medicine, Veterans Administration Medical Center Newington, Connecticut 06111

Address requests for reprints to: Dr. John R. Harrison, Department of Medicine AM-047, University of Connecticut Health Center, Farmington, Connecticut 06032.

Abstract

The effects of recombinant human interleukin-1{alpha} (IL-1) on procollagen gene expression were examined in the clonal mouse osteoblastic cell line MC3T3-E1. Cells were grown in Dulbecco's Modified Eagle's Medium containing 10% fetal calf serum and 50 µg/ml ascorbic acid. Collagen synthesis was assessed as [3H]proline incorporation into collagenase-digestible protein (CDP). Procollagen mRNA levels were determined by Northern blot analysis using a 32P-labeled {alpha}1(I) cDNA. Transcription rates were determined by nuclear run-off assay. IL-1 at 1–1000 pg/ml caused a concentration-dependent inhibition of CDP, which was maximally reduced by 75–80%, and a parallel reduction of procollagen {alpha}1(I) mRNA levels. The effects of IL-1 were mimicked by the tumor promoter phorbol 12-myristate 13-acetate (PMA) at 1–100 nM, which inhibited CDP and reduced procollagen {alpha}1(I) mRNA levels to a similar extent. The effects of IL-1 and PMA were independent of prostaglandin production, since indomethacin did not alter the inhibitory effect of either agent on CDP. Neither IL-1 (up to 10 ng/ml) nor PMA (100 nM) affected adenylate cyclase activity, while forskolin (10 µM), PTH (10 µM) and prostaglandin E2 (1 µM) stimulated adenylate cyclase activity 3- to 5-fold. However, forskolin (10 µM) and (Bu)2cAMP (100 µM) failed to alter CDP or procollagen {alpha}1(I) mRNA levels. IL-1 (1 ng/ml) and PMA (100 nM) reduced transcription of the {alpha}1(I) procollagen gene by 70% and 80%, respectively, while {alpha}2(I) transcription was decreased by 59% and 53%. Neither IL-1 nor PMA affected transcription of the β-actin or β-tubulin genes. In conclusion, IL-1 inhibits collagen synthesis in MC3T3-E1 cells by a transcriptional mechanism which appears to be independent of cAMP. Since PMA mimics the effects of IL-1 on collagen gene expression, protein kinase-C may mediate these actions of IL-1.

FOOTNOTES

A portion of this work was presented at the 11th Annual Meeting of the American Society for Bone and Mineral Research, September 9–14,1989, Montreal, Canada. This work was supported by Grants AR-29850, AM-18063, and AR-31263 from the NIH and funds from the Medical Research Service of the V.A.

* Recipient of National Research Service Award AR-08031 from the NIH.

Received for publication August 21, 1989. Revision received November 1, 1989. Accepted for publication November 1, 1989.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz
Changes in Proinflammatory Cytokine Activity after Menopause
Endocr. Rev., February 1, 2002; 23(1): 90 - 119.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Dodig, MarkS. Kronenberg, A. Bedalov, BarbaraE. Kream, G. Gronowicz, StephenH. Clark, K. Mack, Y.-H. Liu, R. Maxon, Z. Pan, et al.
Identification of a TAAT-containing Motif Required for High Level Expression of the COL1A1 Promoter in Differentiated Osteoblasts of Transgenic Mice
J. Biol. Chem., July 5, 1996; 271(27): 16422 - 16429.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society